IMMUNOMODULATING POLYNUCLEOTIDES, ANTIBODY CONJUGATES THEREOF, AND METHODS OF THEIR USE

MODIFIED DOUBLE-STRANDED RNA AGENTS

RNAi Agents And Compositions for Inhibiting Expression of Apolipoprotein C-III (APOC3)

NUCLEIC ACID COMPOUNDS

DUAL-ACTING siRNA BASED MODULATION OF C9orf72

RNAI CONSTRUCTS FOR INHIBITING PNPLA3 EXPRESSION AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE PCSK9 GENE

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF

COMPOSITIONS AND METHODS FOR IMPROVING STRAND BIASED

AFFINITY REAGENT, MARKER AND METHOD FOR ANALYSING A BIOLOGICAL SAMPLE

AFFINITY REAGENT, MARKER AND METHOD FOR ANALYSING A BIOLOGICAL SAMPLE

RNA INTERFERENCE MEDIATED INHIBITION OF PROLYL HYDROXYLASE DOMAIN 2 (PHD2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)

MODIFIED DOUBLE-STRANDED RNA AGENTS

NUCLEIC ACIDS CONTAINING ABASIC NUCLEOSIDES

ANTISENSE OLIGONUCLEOTIDES HAVING ONE OR MORE ABASIC UNITS

MODIFIED DOUBLE-STRANDED RNA AGENTS

NOVEL PROCESSES FOR THE PRODUCTION OF OLIGONUCLEOTIDES

DOUBLE STRANDED OLIGONUCLEOTIDE COMPOSITIONS AND METHODS RELATING THERETO

MODIFIED NUCLEIC ACID INHIBITING MICRO RNA, AND USE THEREOF

RNA INTERFERENCE MEDIATED INHIBITION OF CATENIN (CADHERIN-ASSOCIATED PROTEIN), BETA 1 (CTNNB1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)

OPTIMIZED 2'- MODIFIED RIBOSE DERIVATIVES AND METHODS OF USE

RNA SILENCING AGENTS AND METHODS OF USE

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE PCSK9 GENE

Stabilized saRNA Compositions and Methods of Use

SNCA IRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING SNCA-ASSOCIATED NEURODEGENERATIVE DISEASES

NUCLEIC ACIDS CONTAINING ABASIC NUCLEOTIDES

RNAi Agents And Compositions for Inhibiting Expression of Apolipoprotein C-III (APOC3)

Modified double-stranded RNA agents

RIG-I Agonists and Methods of Using Same

MODIFIED DOUBLE-STRANDED RNA AGENTS

SYNTHETIC AGONISTS OF DNA-PK AND THEIR USE

RNA INTERFERENCE MEDIATED INHIBITION OF CATENIN (CADHERIN-ASSOCIATED PROTEIN), BETA 1 (CTNNB1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)

RNAi Agents for Inhibiting Expression of Beta-ENaC, Compositions Thereof, and Methods of Use

Twist signaling inhibitor compositions and methods of using the same

THERAPEUTIC INHIBITION OF LACTATE DEHYDROGENASE AND AGENTS THEREFOR

Modified double-stranded RNA agents

RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA)

CRISPR ABASIC RESTRICTED NUCLEOTIDES AND CRISPR ACCURACY VIA ANALOGS

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF

RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (SINA)

COMPOSITIONS AND METHODS OF USING C/EBP ALPHA SARNA

HIGH VISCOSITY MACROMOLECULAR COMPOSITIONS FOR TREATING OCULAR CONDITIONS

Modified double-stranded RNA agents

IMMUNOMODULATING POLYNUCLEOTIDES, ANTIBODY CONJUGATES THEREOF, AND METHODS OF THEIR USE

Targeting Ligands

RNAI CONSTRUCTS FOR INHIBITING PNPLA3 EXPRESSION AND METHODS OF USE THEREOF

MODIFIED DOUBLE-STRANDED RNA AGENTS

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE PCSK9 GENE

Dual-acting siRNA based modulation of C9orf72

SERPINA1 iRNA compositions and methods of use thereof

RNAi Agents And Compositions for Inhibiting Expression of Angiopoietin-Like 3 (ANGPTL3), And Methods Of Use

Compositions and methods for improving strand biased

RIG-I Agonists and Methods of Using Same

Therapeutic inhibition of lactate dehydrogenase and agents therefor

Nucleic acid-polypeptide compositions and uses thereof

RNAi constructs for inhibiting ASGR1 expression and methods of use thereof

OLIGONUCLEOTIDES COMPRISING ACYCLIC AND ABASIC NUCLEOSIDES AND ANALOGS

FUNCTIONAL LIGANDS TO OPIOIDS AND OPIOID METABOLITES

Modified double-stranded RNA agents

RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (SINA)

Compositions and Methods for Inhibiting Expression of the PCSK9 Gene

RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)

STABILIZED SARNA COMPOSITIONS AND METHODS OF USE

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF

Twist signaling inhibitor compositions and methods of using the same

Serpina1 iRNA compositions and methods of use thereof

RNA INTERFERENCE MEDIATED INHIBITION OF CATENIN (CADHERIN-ASSOCIATED PROTEIN), BETA 1 (CTNNB1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)

Therapeutic inhibition of lactate dehydrogenase and agents therefor

RNAi constructs for inhibiting ASGR1 expression and methods of use thereof

Targeting ligands

Modified double-stranded RNA agents

Modified double-stranded RNA agents

RNAi agents and compositions for inhibiting expression of angiopoietin-like 3 (ANGPTL3), and methods of use

RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)

Nucleic acid-polypeptide compositions and uses thereof

Nucleic acid-polypeptide compositions and uses thereof

Oligonucleotides

Serpina1 iRNA compositions and methods of use thereof

Immunomodulating polynucleotides, antibody conjugates thereof, and methods of their use

Compositions and methods for inhibiting expression of the PCSK9 gene

RNA interference mediated inhibition of hepatitis B Virus (HBV) gene expression using short interfering nucleic acid (siNA)

PLATFORM FOR A NON-NATURAL AMINO ACID INCORPORATION INTO PROTEINS

Segmented micro RNA mimetics

RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA)

Single-stranded RNAi agents containing an internal, non-nucleic acid spacer

Targeting ligands

Compositions and methods for inhibition of nucleic acids function

RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)

Therapeutic inhibition of lactate dehydrogenase and agents therefor

Modified double-stranded RNA agents

Twist signaling inhibitor compositions and methods of using the same

Serpina1 iRNA compositions and methods of use thereof

Compositions and methods for inhibition of nucleic acids function

Compositions and methods for inhibiting expression of the PCSK9 gene

CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity

Nucleic acid inducing RNA interference modified for preventing off-target, and use thereof

RNA INTERFERENCE MEDIATED INHIBITION OF PROLYL HYDROXYLASE DOMAIN 2 (PHD2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)

RNA INTERFERENCE MEDIATED INHIBITION OF ISOCITRATE DEHYDROGENASE (IDH1) GENE EXPRESSION

Formats for organic compounds for use in RNA interference

Segmented micro RNA mimetics

Post-synthetic orthogonal amidation plus metal catalyzed azide-alkyne cycloaddition click chemistry on siRNA

Short interfering ribonucleic acid (siRNA) for oral administration

Compositions and methods for inhibition of nucleic acids function

Oligonucleotide compounds comprising non-nucleotide overhangs

Compositions and methods for inhibiting expression of the PCSK9 gene

Serapina1 iRNA compositions and methods of use thereof

CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity

Chimeric immunomodulatory compounds and methods of using the same-IV

RNA interference mediated inhibition of isocitrate dehydrogenase (IDH1) gene expression

Short interfering ribonucleic acid (siRNA) for oral administration

Segmented micro RNA mimetics

Selective inhibition of polyglutamine protein expression

RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA)

Oligonucleotides comprising acyclic and abasic nucleosides and analogs

Oligonucleotide compounds comprising non-nucleotide overhangs

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Chimeric immunomodulatory compounds and methods of using the same-IV

CHEMICAL MODIFICATIONS MOTIFS FOR MIRNA INHIBITORS AND MIMETICS

Modified siNA

Short interfering ribonucleic acid (siRNA) for oral administration

Short interfering ribonucleic acid (siRNA) for oral administration

Short interfering ribonucleic acid (siRNA) for oral administration

Compositions and methods for diminishing viral infection and inflammation associated with viral infection

SIRNA COMPOUNDS AND METHODS OF USE THEREOF

Compositions and methods for inhibition of nucleic acids function

Compositions and methods for inhibiting expression of the PCSK9 gene

ENHANCEMENT OF siRNA SILENCING ACTIVITY USING UNIVERSAL BASES OR MISMATCHES IN THE SENSE STRAND

Potentiation of autoimmune and inflammatory disease treatments by immune regulatory oligonucleotide (IRO) antagonists of TLR7 and TLR9

RNA COMPOSITIONS FOR MODULATING IMMUNE RESPONSE

Double-stranded RNA directed to CASP2 and methods of use thereof

siRNA compounds for inhibiting NRF2

RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA)

MODULATION OF OLIGONUCLEOTIDE CPG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES

RNA INTERFERENCE MEDIATED INHIBITION OF ADENOSINE A1 RECEPTOR (ADORA1) GENE EXPRESSION USING SHORT INTERFERING RNA

RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)

RNA interference mediated treatment of alzheimer's disease using short interfering nucleic acid (siNA)

CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity

RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)

RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)

RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)

RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of checkpoint kinase-1 (CHK-1) gene expression using short interfering nucleic acid (siNA)

Short interfering ribonucleic acid (siRNA) with improved pharmacological properties

Chimeric immunomodulatory compounds and methods of using the same-II

RNA Interference Mediated Inhibition Of Interleukin and Interleukin Gene Expression Using Short Interfering Nucleic Acid (siNA)

Conjugates and compositions for cellular delivery

RNA INTERFERENCE MEDIATED INHIBITION OF B-CELL CLL/LYMPHOMA-2 (BCL2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN TYROSINE PHOSPHATASE-1B (PTP-1B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

Stable and selective formation of hoogsteen-type triplexes and duplexes using twisted intercalating nucleic acids (TINA) and process for the preparation of TINA

Interfering RNA duplex having blunt-ends and 3′-modifications

RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)

METHOD FOR PREVENTION OR TREATMENT OF DISEASES OR DISORDERS RELATED TO EXCESSIVE FORMATION OF VASCULAR TISSUE OR BLOOD VESSELS

RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (SINA)

RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATION CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA interference mediated inhibition of polycomb group protein EZH2 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of muscarinic colinergic receptor gene expression using short interfering nucleic acid (siNA)

RNA INTERFERENCE MEDIATED INHIBITION OF RAS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

RNA interference mediated inhibition of Stearoyl-CoA desaturase (SCD) gene expression using short interfering nucelic acid (siNA)

RNA interference mediated inhibition of MYC and/or MYB gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of XIAP gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of checkpoint kinase-1 (CHK-1) gene expression using short interfering nucleic acid (siNA)

RNA Interference Mediated Inhibition of MAP Kinase Gene Expression or Expression of Genes Involved in MAP Kinase Pathway Using Short Interfering Nucleic Acid (SiNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

High viscosity macromolecular compositions for treating ocular conditions

RNA Interference Mediated Inhibition of Gene Expression Using Short Interfering Nucleic Acid (siNA)

Aptamer-mediated intracellular delivery of oligonucleotides

RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)

Chimeric immunomodulatory compounds and methods of using the same

Compositions and methods for inhibiting expression of the PCSK9 gene

Polycationic compositions for cellular delivery of polynucleotides

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

Rna Interference Mediated Inhibition of Severe Acute Respiratory Syndrome (Sars) Gene Expression Using Short Interfering Nucleic Acid

Interfering Rna Duplex Having Blunt-Ends And 3'-Modifications

Rna interference mediated inhibition of nogo and nogo receptor gene expression using short interfering nucleic acid (sina)

RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)

Rna interference mediated inhibition of xiap gene expression using short interfering nucleic acid (sina)

Chimeric immunomodulatory compounds and methods of using the same—IV

Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)

Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (sina)

Modulation of gene expression associated with inflammation proliferation and neurite outgrowth using nucleic acid based technologies

RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition hairless of (HR) gene expression using short interfering nucleic acid (siNA)

Method for prevention or treatment of diseases or disorders related to excessive formation of vascular tissue or blood vessels

Enzymatic nucleic acid treatment of diseases or conditions related to levels of IKK-gamma and PKR

Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides

RNA interference mediated inhibition of cyclin dependent kinase-2 (CDK2) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of MAP kinase gene expression or expression of genes involved in MAP kinase pathway using short interfering nucleic acid (siNA)

Aptamer-mediated intracellular delivery of therapeutic oligonucleotides

RNA interference mediated inhibition of protein tyrosine phosphatase-1B (PTP-1B) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibtion of protein tyrosine phosphatase-1B (PTP-1B) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of RAS gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering RNA

RNA interference mediated inhibition of stearoyl-CoA desaturase (SCD) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of platelet derived growth factor (PDGF) and platelet derived growth factor receptor (PDGFR) gene expression using short interfering nucleic acid (siNA)

Polycationic compositions for cellular delivery of polynucleotides

Nucleic acid mediated inhibition of enterococcus infection and cytolysin toxin activity

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acis (siNA)

RNA interference mediated treatment of polyglutamine (polyQ) repeat expansion diseases using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of NF-Kappa B / REL-A gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA)

RNA interference mediated inhibition of protein kinase C alpha (PKC-alpha) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of GPRA and AAA1 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of cholinergic muscarinic receptor (CHRM3) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of protein tyrosine phosphatase type IVA (PRL3) gene expression using short interfering nucleic acid (siNA)

Polymearase III-based expression of therapeutic RNAs

RNA interference mediated inhibition of B-cell CLL/Lymphoma-2 (BCL-2) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of epidermal growth factor receptor (EGFR) gene expression using short interfering nucleic acid (siNA)

Chemically modified double stranded nucleic acid molecules

RNA interference mediated inhibition of cholesteryl ester transfer protein (CEPT) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of 5-alpha reductase and androgen receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of ADAM33 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of type 1 insulin-like growth factor receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of polycomb group protein EZH2 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of chromosome translocation gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of angiopoietin gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gastric inhibitory polypeptide (GIP) and gastric inhibitory polypeptide receptor (GIPR) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of Myc and/or Myb gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition 5-alpha reductase and androgen receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of proliferating cell nuclear antigen (PCNA) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of early growth response gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of MDR P-glycoprotein gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA)

RNA interference mediated treatment of Parkinson disease using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of alpha-1 antitrypsin (AAT) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of G72 and D-amino acid oxidase (DAAO) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of wingless gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of CXCR4 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of acetyl-CoA-carboxylase gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of TRPM7 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of myostatin gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of FAS and FASL gene expression using short interfering nucleic acid (siNA)

RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA)

RNA interference mediated treatment of polyglutamine (polyQ) repeat expansion diseases using short interfering nucleic acid (siNA)

Nucleic acid treatment of diseases or conditions related to levels of Ras, HER2 and HIV

RNA interference mediated inhibition of Fos gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibtion of tyrosine phosphatase-1B (PTP-1B) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition hairless (HR) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)

Use of double-stranded ribonucleic acid for inducing cell lysis

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SiNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

RNA interference mediated inhibition of muscarinic cholinergic receptor gene expression using short interfering nucleic acid (siNA)